A five-point change in Modified Mini-Mental State Examination was clinically meaningful in community-dwelling elderly people

Journal of Clinical Epidemiology

Volumn 61, Issue 8, 2008, Pages 827-831

  Andrew, Melissa K ^a   Rockwood, Kenneth ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

3MS; Clinical detectability; Clinical meaningfulness; Cognition; Cognitive decline; Effect size

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; COGNITIVE DEFECT; COMMUNITY CARE; COMMUNITY LIVING; DIAGNOSTIC VALUE; ELDERLY CARE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; MINI MENTAL STATE EXAMINATION; MODIFIED MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; VALIDATION STUDY;

AGED; CANADA; COGNITION DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 45949095922     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.10.022     Document Type: Article

References (21)

1. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987) 314-318
2. Wengreen H.J., Munger R.G., Corcoran C.D., Zandi P., Hayden K.M., Fotuhi M., et al. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging 11 (2007) 230-237
3. Koster A., Penninx B.W., Bosma H., Kempen F.I., Newman A.B., Rubin S.M., et al. Socioeconomic differences in cognitive decline and the role of biomedical factors. Ann Epidemiol 15 (2005) 564-571
4. Shadlen M.F., Siscovick D., Fitzpatrick A.L., Dulberg C., Kuller L.H., and Jackson S. Education, cognitive test scores, and black-white differences in dementia risk. J Am Geriatr Soc 54 (2006) 898-905
5. Yaffe K., Haan M., Blackwell T., Cherkasova E., Whitmer R.A., and West N. Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55 (2007) 758-762
6. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Harris T., Schorr R.J., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 61 (2003) 76-80
7. Maxwell C.J., Hicks M.S., Hogan D.B., Basran J., and Ebly E.M. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord 20 (2005) 45-51
8. Maxwell C.J., Hogan D.B., and Ebly E.M. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 161 (1999) 501-506
9. Correa J.A., Perrault A., and Wolfson C. Reliable individual change scores on the 3MS in older persons with dementia: results from the Canadian Study of Health and Aging. Int Psychogeriatr 13 Suppl 1 (2001) 71-78
10. Bernick C., Katz R., Smith N.L., Rapp S., Bhadekia R., Carlson M., et al. Statins and cognitive function in the elderly: the Cardiovascular Health Study. Neurology 65 (2005) 1388-1394
11. Elkins J.S., Longstreth Jr. W.T., Manolio T.A., Newman A.B., Bhadelia R.A., and Johnston S.C. Education and the cognitive decline associated with MRI-defined brain infarct. Neurology 67 (2006) 435-440
12. Tombaugh T.N. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol 20 (2005) 485-503
13. Cohen J. Statistical power analysis for the behavioral sciences. 2nd edition. (1988), Lawrence Earlbaum Associates, Hillsdale, NJ
14. Rockwood K., and MacKnight C. Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials. Neuroepidemiology 20 (2001) 51-56
15. Rockwood K., McDowell I., and Wolfson C. Canadian Study of Health and Aging. Int Psychogeriatr 13 Suppl 1 (2001) 1-237
16. Thomas V.S., Rockwood K., and McDowell I. Multidimensionality in instrumental and basic activities of daily living. J Clin Epidemiol 51 (1998) 315-321
17. McDowell I. Measuring health. 3rd edition. (2006), Oxford University Press, Oxford
18. Rockwood K., Fay S., Song X., MacKnight C., and Gorman M. Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial. CMAJ 174 (2006) 1099-1105
19. Johnston S.C., O'Meara E.S., Manolio T.A., Lefkowitz D., O'Leary D.H., Goldtein S., et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 140 (2004) 237-247
20. Kuller L.H., Lopez O.L., Newman A., Beauchamp N.J., Burke G., Dulberg C., et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology 22 (2003) 13-22
21. Lopez O.L., Kuller L.H., Fitzpatrick A., Ives D., Becker J.T., and Beauchamp N. Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology 22 (2003) 1-12